Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Enfermedades Infecciosas | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 3
ClinicalTrials.gov
Industry Alliance Platform Trial to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients
INTERVENTIONAL
Inicio: 24 de nov de 2020
ID: NCT04590586
Completado
Fase 2
ClinicalTrials.gov
A Phase 2b Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Preterm Infants
INTERVENTIONAL
Inicio: 3 de nov de 2016
ID: NCT02878330
Terminado
Fase 2
ClinicalTrials.gov
A Randomised, Open Label, Active Controlled Trial to Evaluate the Antiviral Efficacy and Safety of Treatment With 500 mg Tipranavir Plus 100 mg or 200 mg Ritonavir p.o. BID in Combination With Standard Background Regimen in Comparison to 400 mg Lopinavir Plus 100 mg Ritonavir p.o. BID in Combination With Standard Background Regimen in Antiretroviral Therapy Naive Patients for 48 With Extension up to 156 Weeks
INTERVENTIONAL
Inicio: 1 de feb de 2004
ID: NCT00144105
Activo, no recluta
ClinicalTrials.gov
Real World Impact and Effectiveness of ABRYSVO® Vaccination During Pregnancy Against RSV Illness in Infants
OBSERVATIONAL
Inicio: 26 de ago de 2024
ID: NCT06647654
Reclutando
Fase 3
ClinicalTrials.gov
A Phase III, Multi-country, Randomized, Placebo-controlled, Double-blinded Trial to Assess the Efficacy and Safety of Tecovirimat Antiviral Treatment for Patients With Monkeypox Virus Disease
INTERVENTIONAL
Inicio: 3 de mar de 2023
ID: NCT05597735
Completado
Fase 4
ClinicalTrials.gov
Safety of a Second Dose of Biken's Varicella Vaccine Administered at 4 to 6 Years of Age in Healthy Children in Argentina
INTERVENTIONAL
Inicio: 1 de ene de 2009
ID: NCT00830648
Completado
Fase 3
ClinicalTrials.gov
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
INTERVENTIONAL
Inicio: 1 de oct de 2012
ID: NCT01595438
Desconocido
Fase 4
ClinicalTrials.gov
Pilot Study of Safety and Efficacy of Nitazoxanide in Post-exposure Prophylaxis in Household Contacts of Patients With Confirmed SARS-CoV-2 Infection
INTERVENTIONAL
Inicio: 1 de dic de 2020
ID: NCT04788407
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Open Label, Controlled Study of Lopinavir/Ritonavir and Lamivudine Versus Standard Therapy in Naïve HIV-1 Infected Subjects.
INTERVENTIONAL
Inicio: 1 de dic de 2010
ID: NCT01237444
Completado
ClinicalTrials.gov
Interactive Mobile Health Intervention to Support Patients With Active Tuberculosis
INTERVENTIONAL
Inicio: 9 de abr de 2019
ID: NCT03544476
Terminado
Fase 2
ClinicalTrials.gov
A Phase 2b Open-Label Rollover Study For Subjects Discontinuing From UK-453,061 Studies For The Treatment Of HIV-1 Infected Subjects
INTERVENTIONAL
Inicio: 1 de jul de 2009
ID: NCT00824369
Desconocido
ClinicalTrials.gov
Extended Compassionate Use Program (UCA) With Inhalational Ibuprofen in Patients With Acute Respiratory Pathology, Mediated by COVID-19.
INTERVENTIONAL
Inicio: 1 de may de 2020
ID: NCT04382768
Completado
ClinicalTrials.gov
Efficacy of BPS (Bacterial Pneumonia Score) Guided Antibiotic Use in Children With Community Acquired Pneumonia on Reducing Antibiotic Use as Compared to Standard Care Practice (Current Guidelines for CAP) in the Era of Pneumococcal Vaccine
INTERVENTIONAL
Inicio: 1 de jul de 2013
ID: NCT01875731
Completado
ClinicalTrials.gov
Characteristics and Outcomes of Patients With COVID-19-related Acute Respiratory Failure Treated With High-flow Nasal Oxygen and Awake-prone Position
OBSERVATIONAL
Inicio: 15 de abr de 2020
ID: NCT05178212
Terminado
Fase 2
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Clinical Outcomes, Antiviral Activity, Safety, Tolerability, Pharmacokinetics, and Pharmacokinetics/Pharmacodynamics of JNJ-53718678 in Adult and Adolescent Hematopoietic Stem Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper Respiratory Tract
INTERVENTIONAL
Inicio: 26 de dic de 2019
ID: NCT04056611
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Open-Label, Active-Controlled Study to Evaluate a Switch to an Oral Weekly Islatravir/Lenacapavir Regimen in People With HIV-1 Who Are Virologically Suppressed on Standard of Care
INTERVENTIONAL
Inicio: 8 de oct de 2024
ID: NCT06630299
Completado
Fase 2
ClinicalTrials.gov
A Double-blind, Placebo Controlled, Randomized, Phase IIa Study to Assess the Safety, Tolerability, Efficacy, and Pharmacokinetics of Repeated Topical Applications Over 42 Days of AP611074 5% Gel in Condyloma Patients
INTERVENTIONAL
Inicio: 28 de feb de 2012
ID: NCT01532102
Completado
ClinicalTrials.gov
Ventilatory Variables in Subjects With Acute Respiratory Distress Syndrome Due to COVID-19
OBSERVATIONAL
Inicio: 10 de feb de 2023
ID: NCT05946525
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Double-Blind, Randomized, Phase 3 Study to Compare the Efficacy and Safety of Intravenous CXA-201 With That of Meropenem in Complicated Intraabdominal Infections
INTERVENTIONAL
Inicio: 23 de dic de 2011
ID: NCT01445678
Terminado
Fase 2
ClinicalTrials.gov
A Multicenter, Randomized, Open-Label, Active-Controlled Pilot Study to Evaluate the Safety and Antiretroviral Activity of Unboosted Atazanavir BID Plus Raltegravir BID and Boosted Atazanavir QD in Combination With Tenofovir/Emtricitabine QD in Treatment Naive HIV-Infected Subjects
INTERVENTIONAL
Inicio: 1 de nov de 2008
ID: NCT00768989
Anterior
1
...
41
42
43
...
434
Siguiente
Filtros